AAA and Vascular Device Start-Ups
This article was originally published in Start Up
Executive Summary
The first generation less-invasive devices for abdominal aortic aneurysm (AAA) surgery haven't yet been approved and the next generation is already here.
You may also be interested in...
EVAR Market: Challenges, Innovation and Growth
Endovascular aortic aneurysm repair procedures account for the majority of abdominal aortic aneurysm repairs performed in the US, and total worldwide revenues from aortic endograft systems now exceed $1 billion per year. Many believe that continuing improvements in endograft technology will drive EVAR penetration to 90% or beyond within the next five to 10 years. This article first appeared in the April issue of Medtech Insight, April 2011.
Business & Technology Briefs (11/2006)
A short summary of recent product developments in the Orthopedics/Spine, Aesthetics, Stent, Surgery, and Vascular Markets.
Filling in the Gaps in AAA Repair
The first stent grafts created a market for the endovascular repair of abdominal aortic aneurysms. They also created new problems for start-ups to overcome. New companies have risen to the problem of avoiding endoleaks, with new stent graft designs and attachment systems, and also solutions for continuous monitoring.